Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
l-cystine is a sulfur-containing amino acid formed by the oxidation of two molecules of l-cysteine linked by a disulfide bond. It serves as a primary structural component of keratin, making it a common ingredient in nutraceutical formulations for hair and nail health, particularly for androgenetic alopecia (AGA). Beyond its structural role, l-cystine is a critical precursor for the synthesis of the antioxidant glutathione. It is transported into cells via the xCT system (the SLC7A11/SLC3A2 glutamate-cystine antiporter), where it is reduced to cysteine. Emerging research indicates l-cystine may alleviate necrotizing enterocolitis (NEC) by inhibiting ferroptosis and balancing Th17/Treg responses through the IL-6/STAT3 pathway. While used therapeutically for hair loss and studied for gastrointestinal protection, l-cystine is also clinically significant in cystinuria, a condition where impaired renal transport leads to the formation of l-cystine stones in the urinary tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-cystine.